MPTP-induced vulnerability of dopamine neurons in A53T α-synuclein overexpressed mice with the potential involvement of DJ-1 downregulation
- PMID: 29200905
- PMCID: PMC5709479
- DOI: 10.4196/kjpp.2017.21.6.625
MPTP-induced vulnerability of dopamine neurons in A53T α-synuclein overexpressed mice with the potential involvement of DJ-1 downregulation
Abstract
Familial Parkinson's disease (PD) has been linked to point mutations and duplication of the α-synuclein (α-syn) gene. Mutant α-syn expression increases the vulnerability of neurons to exogenous insults. In this study, we developed a new PD model in the transgenic mice expressing mutant hemizygous (hemi) or homozygous (homo) A53T α-synuclein (α-syn Tg) and their wildtype (WT) littermates by treatment with sub-toxic (10 mg/kg, i.p., daily for 5 days) or toxic (30 mg/kg, i.p., daily for 5 days) dose of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Tyrosine hydroxylase and Bcl-2 levels were reduced in the α-syn Tg but not WT mice by sub-toxic MPTP injection. In the adhesive removal test, time to remove paper was significantly increased only in the homo α-syn Tg mice. In the challenging beam test, the hemi and homo α-syn Tg mice spent significantly longer time to traverse as compared to that of WT group. In order to find out responsible proteins related with vulnerability of mutant α-syn expressed neurons, DJ-1 and ubiquitin enzyme expressions were examined. In the SN, DJ-1 and ubiquitin conjugating enzyme, UBE2N, levels were significantly decreased in the α-syn Tg mice. Moreover, A53T α-syn overexpression decreased DJ-1 expression in SH-SY5Y cells. These findings suggest that the vulnerability to oxidative injury such as MPTP of A53T α-syn mice can be explained by downregulation of DJ-1.
Keywords: Apoptosis; DJ-1; MPTP; Parkinson's disease; Synuclein.
Conflict of interest statement
CONFLICTS OF INTEREST: The authors declare no conflicts of interest.
Figures
Similar articles
-
Increased dopaminergic neuron sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in transgenic mice expressing mutant A53T alpha-synuclein.Neurochem Res. 2008 May;33(5):902-11. doi: 10.1007/s11064-007-9533-4. Epub 2007 Nov 13. Neurochem Res. 2008. PMID: 17999181
-
The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.Free Radic Biol Med. 2019 May 1;135:28-37. doi: 10.1016/j.freeradbiomed.2019.02.014. Epub 2019 Feb 20. Free Radic Biol Med. 2019. PMID: 30796974
-
Gami-Chunggan Formula Prevents Motor Dysfunction in MPTP/p-Induced and A53T α-Synuclein Overexpressed Parkinson's Disease Mouse Model Though DJ-1 and BDNF Expression.Front Aging Neurosci. 2019 Aug 28;11:230. doi: 10.3389/fnagi.2019.00230. eCollection 2019. Front Aging Neurosci. 2019. PMID: 31555122 Free PMC article.
-
Transgenic mice with human mutant genes causing Parkinson's disease and amyotrophic lateral sclerosis provide common insight into mechanisms of motor neuron selective vulnerability to degeneration.Rev Neurosci. 2007;18(2):115-36. doi: 10.1515/revneuro.2007.18.2.115. Rev Neurosci. 2007. PMID: 17593875 Review.
-
Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease.Brain Res Mol Brain Res. 2005 Mar 24;134(1):67-75. doi: 10.1016/j.molbrainres.2004.09.011. Brain Res Mol Brain Res. 2005. PMID: 15790531 Free PMC article. Review.
Cited by
-
Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson's Disease.Biomolecules. 2024 Jan 5;14(1):73. doi: 10.3390/biom14010073. Biomolecules. 2024. PMID: 38254673 Free PMC article. Review.
-
The effects of bioactive components from the rhizome of gastrodia elata blume (Tianma) on the characteristics of Parkinson's disease.Front Pharmacol. 2022 Nov 30;13:963327. doi: 10.3389/fphar.2022.963327. eCollection 2022. Front Pharmacol. 2022. PMID: 36532787 Free PMC article. Review.
-
Neurons and Glia Interplay in α-Synucleinopathies.Int J Mol Sci. 2021 May 8;22(9):4994. doi: 10.3390/ijms22094994. Int J Mol Sci. 2021. PMID: 34066733 Free PMC article. Review.
-
Genetic and Environmental Factors Influence the Pleomorphy of LRRK2 Parkinsonism.Int J Mol Sci. 2021 Jan 21;22(3):1045. doi: 10.3390/ijms22031045. Int J Mol Sci. 2021. PMID: 33494262 Free PMC article. Review.
-
Inhibition of Orexin/Hypocretin Neurons Ameliorates Elevated Physical Activity and Energy Expenditure in the A53T Mouse Model of Parkinson's Disease.Int J Mol Sci. 2021 Jan 14;22(2):795. doi: 10.3390/ijms22020795. Int J Mol Sci. 2021. PMID: 33466831 Free PMC article.
References
-
- Habibi E, Masoudi-Nejad A, Abdolmaleky HM, Haggarty SJ. Emerging roles of epigenetic mechanisms in Parkinson's disease. Funct Integr Genomics. 2011;11:523–537. - PubMed
-
- Jenner P, Olanow CW. Understanding cell death in Parkinson's disease. Ann Neurol. 1998;44(3 Suppl 1):S72–S84. - PubMed
-
- de Silva HR, Khan NL, Wood NW. The genetics of Parkinson's disease. Curr Opin Genet Dev. 2000;10:292–298. - PubMed
-
- Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, de Silva HA, Kittel A, Saitoh T. The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron. 1995;14:467–475. - PubMed
-
- Krüger R, Kuhn W, Müller T, Woitalla D, Graeber M, Kösel S, Przuntek H, Epplen JT, Schöls L, Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet. 1998;18:106–108. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
